Cent Eur J Public Health 2008, 16(Supplement):S28-S30

The Future of HPV Screening in Preventing Cervical Cancer

Chris J. L. M. Meijer
Dept of Pathology, Vrije Universiteit Medical Center (VUMC) Amsterdam, The Netherlands

Keywords: HPV, screening, cervical, vaccine, cytology, CIN

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Meijer CJLM. The Future of HPV Screening in Preventing Cervical Cancer. Cent Eur J Public Health. 2008;16(Supplement):S28-30.
Download citation

References

  1. Lörincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med. 2003 Aug;127(8):959-68. Go to original source...
  2. CuzickJ,ClavelC,PetryKU,MeijerCJ,HoyerH,RatnamS,etal.Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006 Sep 1;119(5):1095-101. Go to original source... Go to PubMed...
  3. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med. 2007 Oct 18;357(16):1589-97. Go to original source... Go to PubMed...
  4. Bulkmans NW, Berkhof J, Rozendaal L, van Kemenade FJ, Boeke AJ, Bulk S, et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet. 2007 Nov 24;370(9601):1764-72. Go to original source... Go to PubMed...
  5. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet. 2006 Apr 15;367(9518):1247-55. Go to original source... Go to PubMed...
  6. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S; Females United to Unilaterally Reduce Endo/Ectocervical Disease (FUTURE) I Investigators. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007 May 10;356(19):1928-43. Go to original source... Go to PubMed...